Novartis Investigative Site

León 24080

0 studies enrolling now · 4 studies all time

What they study most

Acute Heart Failure, Carcinoma, Renal Cell, Relapsing Multiple Sclerosis, Thrombocytopaenia

Studies at this site

• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma — Completed
• Global Non-interventional Heart Failure Disease Registry — Stopped early
• A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS) — Stopped early